IMDX Long Put Strategy

IMDX (Insight Molecular Diagnostics Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.

IMDX (Insight Molecular Diagnostics Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $144.9M, a beta of 1.77 versus the broader market, a 52-week range of 2.33-8.51, average daily share volume of 394K, a public-listing history dating back to 2015, approximately 46 full-time employees. These structural characteristics shape how IMDX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.77 indicates IMDX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on IMDX?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current IMDX snapshot

As of June 30, 2026, spot at $5.88, ATM IV 283.90%, IV rank 57.77%, expected move 81.39%. The long put on IMDX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long put structure on IMDX specifically: IMDX IV at 283.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 81.39% (roughly $4.79 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IMDX expiries trade a higher absolute premium for lower per-day decay. Position sizing on IMDX should anchor to the underlying notional of $5.88 per share and to the trader's directional view on IMDX stock.

IMDX long put setup

The IMDX long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IMDX near $5.88, the first option leg uses a $5.88 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IMDX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IMDX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$5.88N/A

IMDX long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

IMDX long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on IMDX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on IMDX

Long puts on IMDX hedge an existing long IMDX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying IMDX exposure being hedged.

IMDX thesis for this long put

The market-implied 1-standard-deviation range for IMDX extends from approximately $1.09 on the downside to $10.67 on the upside. A IMDX long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long IMDX position with one put per 100 shares held. Current IMDX IV rank near 57.77% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on IMDX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, IMDX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IMDX-specific events.

IMDX long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IMDX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IMDX alongside the broader basket even when IMDX-specific fundamentals are unchanged. Long-premium structures like a long put on IMDX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IMDX chain quotes before placing a trade.

Frequently asked questions

What is a long put on IMDX?
A long put on IMDX is the long put strategy applied to IMDX (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With IMDX stock trading near $5.88, the strikes shown on this page are snapped to the nearest listed IMDX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are IMDX long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the IMDX long put priced from the end-of-day chain at a 30-day expiry (ATM IV 283.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a IMDX long put?
The breakeven for the IMDX long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IMDX market-implied 1-standard-deviation expected move is approximately 81.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on IMDX?
Long puts on IMDX hedge an existing long IMDX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying IMDX exposure being hedged.
How does current IMDX implied volatility affect this long put?
IMDX ATM IV is at 283.90% with IV rank near 57.77%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related IMDX analysis